Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
NCT ID: NCT07014111
Last Updated: 2025-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-09-02
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Electrical Stimulation (FES) Exercise Training in Hemodialysis Patients
NCT01956214
Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients
NCT07054112
The Effect of Intradialytic Exercise on the Physical Function of People Undergoing Hemodialysis
NCT03944824
The Effect of Home Based Tel-Exercise on Dialysis Patients
NCT06313892
Sleep and Training Aspects in Dialysis Fatigue - Exercise Intervention
NCT01721551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fight Fatigue
Combined progressive muscle relaxation and walking (increasing step count) 12-week intervention that consists of education/training followed by text messages
Fight Fatigue
Combined progressive muscle relaxation and walking (increasing step count) 12-week intervention that consists of education/training followed by text messages.
Attention Control
End-stage kidney disease education, followed by text messages (over 12 weeks)
Attention Control
End-stage kidney disease education
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fight Fatigue
Combined progressive muscle relaxation and walking (increasing step count) 12-week intervention that consists of education/training followed by text messages.
Attention Control
End-stage kidney disease education
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can read and speak English
* Fatigue measured via visual analogue scale, score ≥4 over the last week
* Able to stand and walk one block
* Has a cell phone that can receive text messages
Exclusion Criteria
* Unstable angina
* Unstable pulmonary disease or pulmonary symptoms that preclude participation
* Lower-extremity amputation without prosthetic (BKA, AKA) -Orthopedic or neurologic condition that would preclude walking or tensing/releasing of muscles-
* Cognitive impairment that, in the judgement of the research team, precludes trial participation
* Participation in the formative phase of the development of Fight Fatigue
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary Hannan
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UI Health/University of Illinois Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY2025-0281
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.